ReviewDrug design, development and therapy2025

NLRP3 Inflammasome Targeting Offers a Novel Therapeutic Paradigm for Sepsis-Induced Myocardial Injury.

Yuzi Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.